Posted inGenetics
Brain Aneurysm Study Identifies Structural, Immune Markers of Rupture Risk
Credit: Nopparit/Getty Images According to some estimates, stroke is the second leading cause of death globally. One of the causes…
Posted inGenetics
Symeres Expands Spray Drying Capabilities at Its U.S. New Jersey Site
Drug development depends on continuity. Keeping discovery chemists, biologists, and CMC experts connected from hit optimization to IND allows scientific…
Posted inBiotechnology
Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones
In this episode of “The Top Line,” recorded on site at Fierce Biotech Week in Boston, Fierce’s Ayla Ellison sits…
Posted inGenetics
Innovative Tech Testing in Response to GMP Revisions
Recent revisions to EU manufacturing guidelines are changing how drug makers test processing technologies, according to the author of a…
Posted inGenetics
Updated Amplification Tool Rapidly Detects Mycoplasma
Nucleic acid amplification techniques (NAAT) are recommended by pharmacopoeias in the United States, the EU, and Japan as an alternative…
Posted inGenetics
Gorilla Adenovirus Brings Natural Edge to Cancer Therapy
When ReiThera’s scientists first turned to a gorilla-derived adenovirus, they were thinking about vaccines. What they found instead might reshape…
Posted inGenetics
In Silico Devices May Improve Drug Manufacturability
Using in silico tools to augment physical experiments can help identify manufacturability issues early in development. That’s according to an…
Posted inGenetics
mRNA Tails Play Key Role in Folding Regulatory Proteins
Credit: Kateryna Kon / Science Photo Library / Getty images mRNA 3′ UTRs have hundreds of highly conserved nucleotides, but…
Posted inGenetics
10x Genomics Acquires Proteintech Genomics, Expanding Proteomics Capablities
10x Genomics has acquired Proteintech Genomics for an undisclosed price, in a deal driven by the buyer’s commitment to expanding…
Posted inResearch
How data-driven diagnostic lab services drive precise clinical trial enrollment
Patient recruitment remains one of the most significant challenges in clinical trial execution. Slow patient accrual is a common cause…